{"transactions":[{"id":786859,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-08T20:22:08.000Z","date":"2026-05-06","kind":"grant","planned":false,"acquired":true,"shares":19824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."}],"balance_after":19824,"derivative":{"underlying":"Class A Common Stock","underlying_shares":19824},"source":{"system":"sec-edgar","filing":"0001628280-26-032904","document":"wk-form4_1778271725.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026032904/wk-form4_1778271725.xml","form_type":"4"}},{"id":786858,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-08T20:22:08.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":false,"shares":34819,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 6, 2025, the reporting person was granted 34,819 restricted stock units vesting on May 7, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 6, 2025, the reporting person was granted 34,819 restricted stock units vesting on May 7, 2026."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":34819},"source":{"system":"sec-edgar","filing":"0001628280-26-032904","document":"wk-form4_1778271725.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026032904/wk-form4_1778271725.xml","form_type":"4"}},{"id":786857,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-08T20:22:08.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":true,"shares":34819,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":320804,"source":{"system":"sec-edgar","filing":"0001628280-26-032904","document":"wk-form4_1778271725.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026032904/wk-form4_1778271725.xml","form_type":"4"}},{"id":9977,"issuer":{"id":2818,"kind":"organization","name":"Philip Morris International Inc."},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-08T18:00:27.000Z","date":"2026-05-06","kind":"grant","planned":false,"acquired":true,"shares":1119,"price":169.93,"value":190151.67,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares awarded under the Philip Morris International Inc. 2017 Stock Compensation Plan for Non-Employee Directors."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The average of the high and low price of Philip Morris International Inc. common stock on May 6, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 8,281 deferred shares held in the Philip Morris International Inc. 2017 Stock Compensation Plan for Non-Employee Directors. This is an increase of 1,361 deferred shares, reflecting the total of the 2026 stock award and 242 deferred shares acquired through the reinvestment of dividends since May 7, 2025, the date of the last reportable transaction."}],"balance_after":10120,"source":{"system":"sec-edgar","filing":"0001628280-26-032727","document":"wk-form4_1778263224.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1413329/000162828026032727/wk-form4_1778263224.xml","form_type":"4"}},{"id":24173,"issuer":{"id":2818,"kind":"organization","name":"Philip Morris International Inc."},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-09T20:53:04.000Z","date":"2025-05-07","kind":"grant","planned":false,"acquired":true,"shares":1002,"price":174.82,"value":175169.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares awarded under the Philip Morris International Inc. 2017 Stock Compensation Plan for Non-Employee Directors."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The average of the high and low price of Philip Morris International Inc. common stock on May 7, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 6,920 deferred shares held in the Philip Morris International Inc. 2017 Stock Compensation Plan for Non-Employee Directors. This is an increase of 1,258 deferred shares, reflecting the total of the 2025 stock award and 256 deferred shares acquired through the reinvestment of dividends since May 8, 2024, the date of the last reportable transaction."}],"balance_after":8759,"source":{"system":"sec-edgar","filing":"0001413329-25-000115","document":"wk-form4_1746823977.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1413329/000141332925000115/wk-form4_1746823977.xml","form_type":"4"}},{"id":1155098,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-08T23:34:41.000Z","date":"2025-05-06","kind":"grant","planned":false,"acquired":true,"shares":34819,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of the stockholders following the date of grant and (ii) the day immediately following the\nfirst anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of the stockholders following the date of grant and (ii) the day immediately following the\nfirst anniversary of the date of grant."}],"balance_after":34819,"derivative":{"underlying":"Class A Common Stock","underlying_shares":34819},"source":{"system":"sec-edgar","filing":"0001628280-25-024000","document":"wk-form4_1746747275.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025024000/wk-form4_1746747275.xml","form_type":"4"}},{"id":1155097,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-08T23:34:41.000Z","date":"2025-05-05","kind":"exercise","planned":false,"acquired":false,"shares":40258,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 2, 2024, the reporting person was granted 40,258 restricted stock units vesting on May 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 2, 2024, the reporting person was granted 40,258 restricted stock units vesting on May 5, 2025."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":40258},"source":{"system":"sec-edgar","filing":"0001628280-25-024000","document":"wk-form4_1746747275.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025024000/wk-form4_1746747275.xml","form_type":"4"}},{"id":1155096,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-05-08T23:34:41.000Z","date":"2025-05-05","kind":"exercise","planned":false,"acquired":true,"shares":40258,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":285985,"source":{"system":"sec-edgar","filing":"0001628280-25-024000","document":"wk-form4_1746747275.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025024000/wk-form4_1746747275.xml","form_type":"4"}},{"id":1517590,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-14T20:39:54.000Z","date":"2024-05-10","kind":"exercise","planned":false,"acquired":false,"shares":76453,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 9, 2023 the reporting person was granted 76,453 restricted stock units vesting on May 10, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 9, 2023 the reporting person was granted 76,453 restricted stock units vesting on May 10, 2024."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":76453},"source":{"system":"sec-edgar","filing":"0001628280-24-023244","document":"wk-form4_1715719176.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024023244/wk-form4_1715719176.xml","form_type":"4"}},{"id":1517589,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-05-14T20:39:54.000Z","date":"2024-05-10","kind":"exercise","planned":false,"acquired":true,"shares":76453,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":245727,"source":{"system":"sec-edgar","filing":"0001628280-24-023244","document":"wk-form4_1715719176.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024023244/wk-form4_1715719176.xml","form_type":"4"}},{"id":41001,"issuer":{"id":2818,"kind":"organization","name":"Philip Morris International Inc."},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-10T20:31:20.000Z","date":"2024-05-08","kind":"grant","planned":false,"acquired":true,"shares":1789,"price":97.84,"value":175035.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares awarded under the Philip Morris International Inc. 2017 Stock Compensation Plan for Non-Employee Directors."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The average of the high and low price of Philip Morris International Inc. common stock on May 8, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 5,662 deferred shares held in the Philip Morris International Inc. 2017 Stock Compensation Plan for Non-Employee Directors. This is an increase of 1,995 deferred shares, reflecting the total of the 2024 stock award and 206 deferred shares acquired through the reinvestment of dividends since May 3, 2023, the date of the last reportable transaction."}],"balance_after":7501,"source":{"system":"sec-edgar","filing":"0001413329-24-000120","document":"wk-form4_1715373069.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1413329/000141332924000120/wk-form4_1715373069.xml","form_type":"4"}},{"id":1526382,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-06T21:38:39.000Z","date":"2024-05-02","kind":"grant","planned":false,"acquired":true,"shares":40258,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."}],"balance_after":40258,"derivative":{"underlying":"Class A Common Stock","underlying_shares":40258},"source":{"system":"sec-edgar","filing":"0001628280-24-020746","document":"wk-form4_1715031510.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024020746/wk-form4_1715031510.xml","form_type":"4"}},{"id":1896766,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-11T20:15:24.000Z","date":"2023-05-10","kind":"exercise","planned":false,"acquired":false,"shares":80128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On May 9, 2022 the reporting person was granted 80,128 restricted stock units vesting on May 10, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On May 9, 2022 the reporting person was granted 80,128 restricted stock units vesting on May 10, 2023."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":80128},"source":{"system":"sec-edgar","filing":"0001209191-23-028732","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123028732/doc4.xml","form_type":"4"}},{"id":1896765,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-11T20:15:24.000Z","date":"2023-05-09","kind":"grant","planned":false,"acquired":true,"shares":76453,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."}],"balance_after":76453,"derivative":{"underlying":"Class A Common Stock","underlying_shares":76453},"source":{"system":"sec-edgar","filing":"0001209191-23-028732","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123028732/doc4.xml","form_type":"4"}},{"id":1896764,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-05-11T20:15:24.000Z","date":"2023-05-10","kind":"exercise","planned":false,"acquired":true,"shares":80128,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":169274,"source":{"system":"sec-edgar","filing":"0001209191-23-028732","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123028732/doc4.xml","form_type":"4"}},{"id":56123,"issuer":{"id":2818,"kind":"organization","name":"Philip Morris International Inc."},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-05T22:03:19.000Z","date":"2023-05-03","kind":"grant","planned":false,"acquired":true,"shares":1812,"price":96.58,"value":175002.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares awarded under the Philip Morris International Inc. 2017 Stock Compensation Plan for Non-Employee Directors."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The average of the high and low price of Philip Morris International Inc. common stock on May 3, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 3,667 deferred shares held in the Philip Morris International Inc. 2017 Stock Compensation Plan for Non-Employee Directors. This is an increase of 1,908 deferred shares, reflecting the total of the 2023 stock award and 96 deferred shares acquired through the reinvestment of dividends since May 4, 2022, the date of the last reportable transaction."}],"balance_after":5506,"source":{"system":"sec-edgar","filing":"0001413329-23-000145","document":"wf-form4_168332418448894.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1413329/000141332923000145/wf-form4_168332418448894.xml","form_type":"4"}},{"id":2276256,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-05-10T22:59:41.000Z","date":"2022-05-09","kind":"grant","acquired":true,"shares":80128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."}],"balance_after":80128,"derivative":{"underlying":"Class A Common Stock","underlying_shares":80128},"source":{"system":"sec-edgar","filing":"0001209191-22-028165","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122028165/doc4.xml","form_type":"4"}},{"id":2276255,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-05-10T22:59:41.000Z","date":"2022-05-08","kind":"exercise","acquired":false,"shares":35406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 5, 2021 the reporting person was granted 35,406 restricted stock units vesting on May 8, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 5, 2021 the reporting person was granted 35,406 restricted stock units vesting on May 8, 2022."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":35406},"source":{"system":"sec-edgar","filing":"0001209191-22-028165","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122028165/doc4.xml","form_type":"4"}},{"id":2276254,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-05-10T22:59:41.000Z","date":"2022-05-08","kind":"exercise","acquired":true,"shares":35406,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":89146,"source":{"system":"sec-edgar","filing":"0001209191-22-028165","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122028165/doc4.xml","form_type":"4"}},{"id":66513,"issuer":{"id":2818,"kind":"organization","name":"Philip Morris International Inc."},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-06T20:57:50.000Z","date":"2022-05-04","kind":"grant","acquired":true,"shares":1759,"price":99.53,"value":175073.27,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares awarded under the Philip Morris International Inc. 2017 Stock Compensation Plan for Non-Employee Directors."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The average of the high and low price of Philip Morris International Inc. common stock on May 5, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,759 deferred shares held in the Philip Morris International Inc. 2017 Stock Compensation Plan for Non-Employee Directors. This is an increase of 1,759 deferred shares, reflecting the 2022 stock award since May 5, 2021, the date of the last reportable transaction."}],"balance_after":3598,"source":{"system":"sec-edgar","filing":"0001182489-22-000037","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1413329/000118248922000037/edgar.xml","form_type":"4"}},{"id":2562297,"issuer":{"id":135295,"kind":"organization","name":"W R GRACE & CO","symbol":"GRA"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2021-09-22T17:25:46.000Z","date":"2021-09-22","kind":"disposition_to_issuer","acquired":false,"shares":6973,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the Agreement & Plan of Merger (the \"Merger Agreement\"), dated April 26, 2021, among W. R. Grace & Co. (\"Company\"), W. R. Grace Holdings LLC (fka Gibraltar Acquisition Holdings LLC), a Delaware limited liability company (\"Parent\"), and Gibraltar Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Parent (\"Merger Sub\"), filed as Exhibit 2.1 to the Company's Form 8-K filed with the SEC on April 26, 2021, pursuant to which on Sept. 22, 2021, Merger Sub merged with and into the Company (the \"Merger\") and pursuant to which the Company survived the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the \"Effective Time\"), each issued & outstanding share of Company common stock was cancelled and converted into the right to receive $70.00 in cash (the \"Merger Consideration\") without interest, subject to withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001045309-21-000099","document":"wf-form4_163234593412874.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1045309/000104530921000099/wf-form4_163234593412874.xml","form_type":"4"}},{"id":2716955,"issuer":{"id":135295,"kind":"organization","name":"W R GRACE & CO","symbol":"GRA"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2021-05-12T19:55:56.000Z","date":"2021-05-11","kind":"grant","acquired":true,"shares":1683,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Issued in partial payment for 2021 retainer."}],"balance_after":6973,"source":{"system":"sec-edgar","filing":"0001045309-21-000068","document":"wf-form4_162086374286202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1045309/000104530921000068/wf-form4_162086374286202.xml","form_type":"4"}},{"id":88243,"issuer":{"id":2818,"kind":"organization","name":"Philip Morris International Inc."},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-07T20:51:45.000Z","date":"2021-05-05","kind":"grant","acquired":true,"shares":1839,"price":95.175,"value":175026.825,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares awarded under the Philip Morris International Inc. 2017 Stock Compensation Plan for Non-Employee Directors."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The average of the high and low price of Philip Morris International Inc. common stock on May 5, 2021."}],"balance_after":1839,"source":{"system":"sec-edgar","filing":"0001182489-21-000102","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1413329/000118248921000102/edgar.xml","form_type":"4"}},{"id":2723256,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-05-07T18:10:46.000Z","date":"2021-05-06","kind":"exercise","acquired":false,"shares":46218,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On May 5, 2020 the reporting person was granted 46,218 restricted stock units vesting on May 6, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On May 5, 2020 the reporting person was granted 46,218 restricted stock units vesting on May 6, 2021."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":46218},"source":{"system":"sec-edgar","filing":"0001209191-21-030815","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121030815/doc4.xml","form_type":"4"}},{"id":2723255,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-05-07T18:10:46.000Z","date":"2021-05-05","kind":"grant","acquired":true,"shares":35406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."}],"balance_after":35406,"derivative":{"underlying":"Class A Common Stock","underlying_shares":35406},"source":{"system":"sec-edgar","filing":"0001209191-21-030815","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121030815/doc4.xml","form_type":"4"}},{"id":2723254,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-05-07T18:10:46.000Z","date":"2021-05-06","kind":"exercise","acquired":true,"shares":46218,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":53740,"source":{"system":"sec-edgar","filing":"0001209191-21-030815","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121030815/doc4.xml","form_type":"4"}},{"id":2938059,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-12-18T21:12:34.000Z","date":"2020-12-15","kind":"exercise","acquired":false,"shares":7522,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On December 14, 2019, the reporting person was granted 7,522 restricted stock units vesting December 15, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On December 14, 2019, the reporting person was granted 7,522 restricted stock units vesting December 15, 2020."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":7522},"source":{"system":"sec-edgar","filing":"0001209191-20-064386","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919120064386/doc4.xml","form_type":"4"}},{"id":2938058,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2020-12-18T21:12:34.000Z","date":"2020-12-15","kind":"exercise","acquired":true,"shares":7522,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":7522,"source":{"system":"sec-edgar","filing":"0001209191-20-064386","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919120064386/doc4.xml","form_type":"4"}},{"id":3149365,"issuer":{"id":135295,"kind":"organization","name":"W R GRACE & CO","symbol":"GRA"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2020-05-14T17:10:02.000Z","date":"2020-05-12","kind":"grant","acquired":true,"shares":2280,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Issued in partial payment for 2020 retainer."}],"balance_after":5290,"source":{"system":"sec-edgar","filing":"0001045309-20-000079","document":"wf-form4_158949058450674.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1045309/000104530920000079/wf-form4_158949058450674.xml","form_type":"4"}},{"id":3159667,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-05-06T23:50:16.000Z","date":"2020-05-05","kind":"grant","acquired":true,"shares":46218,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."}],"balance_after":46218,"derivative":{"underlying":"Class A Common Stock","underlying_shares":46218},"source":{"system":"sec-edgar","filing":"0000899243-20-012187","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924320012187/doc4.xml","form_type":"4"}},{"id":3339191,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-12-17T22:44:44.000Z","date":"2019-12-14","kind":"grant","acquired":true,"shares":7522,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.  Restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.  Restricted stock units have no expiration date."}],"balance_after":7522,"derivative":{"underlying":"Class A Common Stock","underlying_shares":7522},"source":{"system":"sec-edgar","filing":"0001723128-19-000146","document":"wf-form4_157662266649783.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000146/wf-form4_157662266649783.xml","form_type":"4"}},{"id":3339190,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-12-17T22:44:44.000Z","date":"2019-12-14","kind":"grant","acquired":true,"shares":28506,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."}],"balance_after":28506,"derivative":{"exercise_price":4.76,"expiration_date":"2029-12-14","underlying":"Class A Common Stock","underlying_shares":28506},"source":{"system":"sec-edgar","filing":"0001723128-19-000146","document":"wf-form4_157662266649783.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000146/wf-form4_157662266649783.xml","form_type":"4"}},{"id":3351668,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy","published_at":"2019-12-05T13:43:02.000Z","date":"2019-12-04","kind":"exercise","acquired":true,"shares":2766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each option to purchase shares of Company Common Stock (each, a \"Company Option\") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration.  The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each option to purchase shares of Company Common Stock (each, a \"Company Option\") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration.  The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option."}],"balance_after":0,"derivative":{"exercise_price":40.06,"underlying":"Common Stock","underlying_shares":2766},"source":{"system":"sec-edgar","filing":"0001209191-19-059249","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119059249/doc4.xml","form_type":"4"}},{"id":3351667,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-12-05T13:43:02.000Z","date":"2019-12-04","kind":"exercise","acquired":true,"shares":1980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each option to purchase shares of Company Common Stock (each, a \"Company Option\") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration.  The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each option to purchase shares of Company Common Stock (each, a \"Company Option\") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration.  The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option."}],"balance_after":0,"derivative":{"exercise_price":53.7,"underlying":"Common Stock","underlying_shares":1980},"source":{"system":"sec-edgar","filing":"0001209191-19-059249","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119059249/doc4.xml","form_type":"4"}},{"id":3351666,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-12-05T13:43:02.000Z","date":"2019-12-04","kind":"exercise","acquired":true,"shares":1577,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each option to purchase shares of Company Common Stock (each, a \"Company Option\") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration.  The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each option to purchase shares of Company Common Stock (each, a \"Company Option\") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration.  The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option."}],"balance_after":0,"derivative":{"exercise_price":58.98,"underlying":"Common Stock","underlying_shares":1577},"source":{"system":"sec-edgar","filing":"0001209191-19-059249","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119059249/doc4.xml","form_type":"4"}},{"id":3351665,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-12-05T13:43:02.000Z","date":"2019-12-04","kind":"exercise","acquired":true,"shares":1613,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each option to purchase shares of Company Common Stock (each, a \"Company Option\") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration.  The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each option to purchase shares of Company Common Stock (each, a \"Company Option\") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration.  The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option."}],"balance_after":0,"derivative":{"exercise_price":45.12,"underlying":"Common Stock","underlying_shares":1613},"source":{"system":"sec-edgar","filing":"0001209191-19-059249","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119059249/doc4.xml","form_type":"4"}},{"id":3351664,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-12-05T13:43:02.000Z","date":"2019-12-04","kind":"exercise","acquired":true,"shares":2140,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each option to purchase shares of Company Common Stock (each, a \"Company Option\") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration.  The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each option to purchase shares of Company Common Stock (each, a \"Company Option\") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration.  The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option."}],"balance_after":0,"derivative":{"exercise_price":41.225,"underlying":"Common Stock","underlying_shares":2140},"source":{"system":"sec-edgar","filing":"0001209191-19-059249","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119059249/doc4.xml","form_type":"4"}},{"id":3351663,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-12-05T13:43:02.000Z","date":"2019-12-04","kind":"exercise","acquired":true,"shares":3863,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each option to purchase shares of Company Common Stock (each, a \"Company Option\") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration.  The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each option to purchase shares of Company Common Stock (each, a \"Company Option\") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration.  The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option."}],"balance_after":0,"derivative":{"exercise_price":21.7,"underlying":"Common Stock","underlying_shares":3863},"source":{"system":"sec-edgar","filing":"0001209191-19-059249","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119059249/doc4.xml","form_type":"4"}},{"id":3351662,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-12-05T13:43:02.000Z","date":"2019-12-04","kind":"exercise","acquired":true,"shares":6371,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each option to purchase shares of Company Common Stock (each, a \"Company Option\") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration.  The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each option to purchase shares of Company Common Stock (each, a \"Company Option\") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration.  The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option."}],"balance_after":0,"derivative":{"exercise_price":12.9,"underlying":"Common Stock","underlying_shares":6371},"source":{"system":"sec-edgar","filing":"0001209191-19-059249","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119059249/doc4.xml","form_type":"4"}},{"id":3351661,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-05T13:43:02.000Z","date":"2019-12-04","kind":"sale","acquired":false,"shares":35796,"price":60,"value":2147760.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of for $60.00 per share pursuant to the terms of that certain Agreement and Plan of Merger dated as of August 7, 2019, by and among Catalog Intermediate Inc. (\"Parent\"), Catalog Merger Sub (\"Merger Sub\"), each entities controlled by investment funds advised by Permira Advisors LLC, and the Company (the \"Merger Agreement\").  All terms capitalized but not defined shall have the respective meanings given to them in the Merger Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-059249","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119059249/doc4.xml","form_type":"4"}},{"id":3351660,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-05T13:43:02.000Z","date":"2019-12-04","kind":"exercise","acquired":true,"shares":2766,"price":40.06,"value":110805.96,"ownership":{"direct":true},"balance_after":35796,"source":{"system":"sec-edgar","filing":"0001209191-19-059249","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119059249/doc4.xml","form_type":"4"}},{"id":3351659,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-05T13:43:02.000Z","date":"2019-12-04","kind":"exercise","acquired":true,"shares":1980,"price":53.7,"value":106326.0,"ownership":{"direct":true},"balance_after":33030,"source":{"system":"sec-edgar","filing":"0001209191-19-059249","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119059249/doc4.xml","form_type":"4"}},{"id":3351658,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-05T13:43:02.000Z","date":"2019-12-04","kind":"exercise","acquired":true,"shares":1577,"price":58.98,"value":93011.46,"ownership":{"direct":true},"balance_after":31050,"source":{"system":"sec-edgar","filing":"0001209191-19-059249","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119059249/doc4.xml","form_type":"4"}},{"id":3351657,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-05T13:43:02.000Z","date":"2019-12-04","kind":"exercise","acquired":true,"shares":1613,"price":45.12,"value":72778.56,"ownership":{"direct":true},"balance_after":29473,"source":{"system":"sec-edgar","filing":"0001209191-19-059249","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119059249/doc4.xml","form_type":"4"}},{"id":3351656,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-05T13:43:02.000Z","date":"2019-12-04","kind":"exercise","acquired":true,"shares":2140,"price":41.225,"value":88221.5,"ownership":{"direct":true},"balance_after":27860,"source":{"system":"sec-edgar","filing":"0001209191-19-059249","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119059249/doc4.xml","form_type":"4"}},{"id":3351655,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-05T13:43:02.000Z","date":"2019-12-04","kind":"exercise","acquired":true,"shares":3863,"price":21.7,"value":83827.1,"ownership":{"direct":true},"balance_after":25720,"source":{"system":"sec-edgar","filing":"0001209191-19-059249","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119059249/doc4.xml","form_type":"4"}},{"id":3351654,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-05T13:43:02.000Z","date":"2019-12-04","kind":"exercise","acquired":true,"shares":6371,"price":12.9,"value":82185.9,"ownership":{"direct":true},"balance_after":21857,"source":{"system":"sec-edgar","filing":"0001209191-19-059249","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119059249/doc4.xml","form_type":"4"}},{"id":3480585,"issuer":{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-25T01:44:19.000Z","date":"2019-06-20","kind":"grant","acquired":true,"shares":126050,"price":3,"value":378150.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options shall vest on a monthly basis pro rata over the twelve (12) months following the grant date, provided that the recipient's continuous service has not terminated prior to the applicable vesting date."}],"balance_after":126050,"derivative":{"exercise_price":3,"expiration_date":"2029-06-19","underlying":"Common stock","underlying_shares":126050},"source":{"system":"sec-edgar","filing":"0000882104-19-000075","document":"wf-form4_156142704350468.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882104/000088210419000075/wf-form4_156142704350468.xml","form_type":"4"}},{"id":3533904,"issuer":{"id":135295,"kind":"organization","name":"W R GRACE & CO","symbol":"GRA"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2019-05-09T18:39:30.000Z","date":"2019-05-08","kind":"grant","acquired":true,"shares":1532,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Issued in partial payment for 2019 retainer."}],"balance_after":3010,"source":{"system":"sec-edgar","filing":"0001045309-19-000072","document":"wf-form4_155744155621515.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1045309/000104530919000072/wf-form4_155744155621515.xml","form_type":"4"}},{"id":3549382,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-04-25T20:35:50.000Z","date":"2019-04-24","kind":"grant","acquired":true,"shares":2766,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2766,"derivative":{"exercise_price":40.06,"exercise_date":"2019-10-24","expiration_date":"2026-04-23","underlying":"Common Stock","underlying_shares":2766},"source":{"system":"sec-edgar","filing":"0001209191-19-026063","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119026063/doc4.xml","form_type":"4"}},{"id":3549381,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-25T20:35:50.000Z","date":"2019-04-24","kind":"grant","acquired":true,"shares":2247,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15486,"source":{"system":"sec-edgar","filing":"0001209191-19-026063","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119026063/doc4.xml","form_type":"4"}},{"id":3897538,"issuer":{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2018-06-12T20:29:26.000Z","date":"2018-06-08","kind":"grant","acquired":true,"shares":54348,"price":2.76,"value":150000.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The grant will cliff-vest on the first anniversary of the date of grant so long as the grant recipient continues to serve on the Board of Directors of PDL BioPharma, Inc."}],"balance_after":54348,"source":{"system":"sec-edgar","filing":"0000882104-18-000066","document":"wf-form4_152883534801960.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882104/000088210418000066/wf-form4_152883534801960.xml","form_type":"4"}},{"id":3937359,"issuer":{"id":135295,"kind":"organization","name":"W R GRACE & CO","symbol":"GRA"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2018-05-11T16:25:59.000Z","date":"2018-05-09","kind":"grant","acquired":true,"shares":1478,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Issued in partial payment for 2018 retainer."}],"balance_after":1478,"source":{"system":"sec-edgar","filing":"0001045309-18-000079","document":"wf-form4_152607029912157.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1045309/000104530918000079/wf-form4_152607029912157.xml","form_type":"4"}},{"id":3954144,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-04-30T20:49:36.000Z","date":"2018-04-26","kind":"grant","acquired":true,"shares":1980,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1980,"derivative":{"exercise_price":53.7,"exercise_date":"2018-10-26","expiration_date":"2025-04-25","underlying":"Common Stock","underlying_shares":1980},"source":{"system":"sec-edgar","filing":"0001209191-18-026948","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919118026948/doc4.xml","form_type":"4"}},{"id":3954143,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-30T20:49:36.000Z","date":"2018-04-26","kind":"grant","acquired":true,"shares":1397,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13239,"source":{"system":"sec-edgar","filing":"0001209191-18-026948","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919118026948/doc4.xml","form_type":"4"}},{"id":4256956,"issuer":{"id":76832,"kind":"organization","name":"Exela Technologies, Inc."},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-15T01:16:35.000Z","date":"2017-07-12","kind":"disposition_to_issuer","acquired":false,"shares":29500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"To facilitate a business combination involving the Issuer, SourceHOV Holdings, Inc. and Novitex Holdings Inc., which closed July 12, 2017 (the \"Business Combination\"), Mr. Yanai forfeited to the Issuer 29,500 shares of common stock.  No consideration was received by Mr. Yanai for the disposition. Also in connection with the Business Combination, Mr. Yanai resigned his position as a director of the company effective the closing date, and as such, Mr. Yanai is no longer subject to the reporting obligations under Section 16 with respect to the Issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Mr. Yanai disclaims beneficial ownership in shares held by Quinpario Partners 2, LLC, except to the extent of his pecuniary interest therein."}],"balance_after":20500,"source":{"system":"sec-edgar","filing":"0001104659-17-045127","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1562645/000110465917045127/a4.xml","form_type":"4"}},{"id":4341017,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2017-05-01T16:18:57.000Z","date":"2017-04-27","kind":"grant","acquired":true,"shares":1577,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1577,"derivative":{"exercise_price":58.98,"exercise_date":"2017-10-27","expiration_date":"2024-04-26","underlying":"Common Stock","underlying_shares":1577},"source":{"system":"sec-edgar","filing":"0001437749-17-007613","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/820081/000143774917007613/rdgdoc.xml","form_type":"4"}},{"id":4341016,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-05-01T16:18:57.000Z","date":"2017-04-27","kind":"grant","acquired":true,"shares":1187,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11842,"source":{"system":"sec-edgar","filing":"0001437749-17-007613","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/820081/000143774917007613/rdgdoc.xml","form_type":"4"}}]}